T3D Therapeutics

About

T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.

Durham,North Carolina,United States
1 - 10

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $6M
Industries: Biotechnology,Medical,Therapeutics
Founded date: Jan 1, 2013
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: T3D Therapeutics Inc.

T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation' and neurodegeneration of Alzheimer's disease and helps in treating multiple manifestations of the disease, providing Alzheimer patients with a drug to potentially improve multiple defects and improve memory, motor function and cognition.

T3D Therapeutics is based in Durham, North Carolina, and was founded in 2013.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

8

$40.31M

T3D Therapeutics has raised a total of $40.31M in funding over 2 rounds. Their latest funding was raised on Sep 3, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 3, 2022	Series Unknown	$6M	—	—	—	Detail
Nov 4, 2019	Series B	$15M	1	National Institute on Aging	—	Detail
May 21, 2019	Grant	$9M	—	—	—	Detail
Mar 10, 2018	Series Unknown	$6M	—	—	—	Detail
Mar 11, 2016	Seed	$1.21M	—	—	—	Detail